AKT1 and cancer: In a panel of cancer cell lines, shown in Figure 1A, inhibition of AKT with MK2206 clearly inhibited phosphorylation of PRAS40 at Thr246, whereas inhibition of mTORC1 with rapamycin did not affect the Thr246 phosphorylation (Figure 4A).